39
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Angiographic no-reflow and six-month mortality in elderly (≥ 75 years old) Asian patients undergoing primary percutaneous coronary intervention: A single center experience from 1998 to 2007

, , , , &
Pages 63-69 | Published online: 05 May 2010

References

  • Holmes DR Jr, White HD, Pieper KS, Ellis SG, Califf RM, Topol EJ. Effect of age on outcome with primary angioplasty versus thrombolysis. J Am Coll Cardiol. 1999;33:412–9.
  • DeGeare VS, Stone GW, Grines L, Brodie BR, Cox DA, Garcia E, . Angiographic and clinical characteristics associated with increased inhospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials). Am J Cardiol. 2000;86:30–4.
  • Lee CH, van Domburg RT, Hoye A, Lemos PA, Tanabe K, Smits PC, . Predictors of survival after contemporary percutaneous coronary revascularization for acute myocardial infarction in the real world. J Invasive Cardiol. 2004;16:627–31.
  • Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003;361:13–20.
  • Boersma E, The Primary Coronary Angioplasty vs. Thrombolysis Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J. 2006;27:779–88.
  • Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O’Keefe J, . A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1993;328:673–9.
  • The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. N Engl J Med. 1997;336:1621–8.
  • Senior PAMI: Primary PCI not better than lytic therapy in elderly patients. Available at: http://www.theheart.org/article/581549.do. Accessed 14 October 2008.
  • Lev EI, Kornowski R, Vaknin-Assa H, Porter A, Teplitsky I, Ben-Dor I, . Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2008;102:6–11.
  • Lee TC, Laramee LA, Rutherford BD, McConahay DR, , Johnson WL JrGiorgi LV, . Emergency percutaneous transluminal coronary angioplasty for acute myocardial infarction in patients 70 years of age and older. Am J Cardiol. 1990;66:663–7.
  • Laster SB, Rutherford BD, Giorgi LV, Shimshak TM, McConahay DR, Johnson WL Jr, . Results of direct percutaneous transluminal coronary angioplasty in octogenarians. Am J Cardiol. 1996;77:10–13.
  • Wang YC, Hwang JJ, Hung CS, Kao HL, Chiang FT, Tseng CD. Outcome of primary percutaneous coronary intervention in octogenarians with acute myocardial infarction. J Formos Med Assoc. 2006;105:451–8.
  • Valente S, Lazzeri C, Salvadori C, Chiostri M, Giglioli C, Poli S, . Effectiveness and safety of routine primary angioplasty in patients aged>or=85 years with acute myocardial infarction. Circ J. 2008;72:67–70.
  • Antoniucci D, Valenti R, Santoro GM, Bolognese L, Moschi G, Trapani M, . Systematic primary angioplasty in octogenarian and older patients. Am Heart J. 1999;138:670–4.
  • Wenaweser P, Ramser M, Windecker S, Lütolf I, Meier B, Seiler C, . Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2007;70:485–90.
  • Guagliumi G, Stone GW, Cox DA, Stuckey T, Tcheng JE, Turco M, . Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: Results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation 2004;110:1598–604.
  • de Boer MJ, Ottervanger JP, van 't Hof AW, Hoorntje JC, Suryapranata H, Zijlstra F; Zwolle Myocardial Infarction Study Group. Reperfusion therapy in elderly patients with acute myocardial infarction: A randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol. 2002;39:1723–8.
  • TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312:932–6.
  • Gibson CM, Murphy SA, Rizzo MJ, Ryan KA, Marble SJ, McCabe CH, . Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis in Myocardial Infarction (TIMI) Study Group. Circulation. 1999;99:1945–50.
  • Gibson CM, Murphy S, Menown IB, Sequeira RF, Greene R, Van de Werf F, . Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1999;34:1403–12.
  • Holmes DR Jr, White HD, Pieper KS, Ellis SG, Califf RM, Topol EJ. Effect of age on outcome with primary angioplasty versus thrombolysis. J Am Coll Cardiol. 1999;33:412–9.
  • Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, . Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000;36:1202–9.
  • Brosh D, Assali AR, Mager A, Porter A, Hasdai D, Teplitsky I, . Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol. 2007;99:442–5.
  • Antoniucci D, Valenti R, Migliorini A, Moschi G, Trapani M, Buonamici P, . Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol. 2002;89:1248–52.
  • Tarantini G, Cacciavillani L, Corbetti F, Ramondo A, Marra MP, Bacchiega E, . Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol. 2005;46:1229–35.
  • De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109:1223–1225.
  • Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, . American College of Cardiology; American Heart Association Task Force on Practice Guidelines; Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). 2004;110:e82–e292.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.